Targeting iron-metabolism:a potential therapeutic strategy for pulmonary fibrosis
Open Access
- 15 February 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 172, 116270
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Yunnan Provincial Science and Technology Department
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China (82360017)
This publication has 108 references indexed in Scilit:
- Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damageAnnals of the Rheumatic Diseases, 2012
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell DeathCell, 2012
- Macrophage plasticity and polarization: in vivo veritasJournal of Clinical Investigation, 2012
- Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseasesPharmacology & Therapeutics, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- System xc‐ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNSBritish Journal of Pharmacology, 2011
- The oxidative stress-inducible cystine/glutamate antiporter, system x c − : cystine supplier and beyondAmino Acids, 2011
- BMP6 is a key endogenous regulator of hepcidin expression and iron metabolismNature Genetics, 2009
- Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)Journal of Clinical Investigation, 2007
- Telomerase Mutations in Families with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 2007